All in all, we initially found that MYC induced HNF1A‐AS1 overexpression promoted glioma progression via modulating miR‐32‐5p/SOX4 axis, providing potent reference value for targeting HNF1A‐AS1 in future therapeutic strategies of glioma. This evidence concerns the gene HNF1A and central nervous system cancer.